Scully Backs Docs In ICD Coverage Decision Process; McClellan Weighs Cost
This article was originally published in The Gray Sheet
Executive Summary
CMS Administrator Tom Scully is citing unresolved clinical questions raised by the pending ICD coverage decision as the reason for its potential delay beyond the June timeframe
You may also be interested in...
Biotronik Markets $10,000 Cardiac Airbag ICD Via Direct Sales Website
Biotronik's Cardiac Airbag is the first device tailored as a cheaper alternative to state-of-the-art ICDs as CMS weighs expanded coverage of the costly therapy
Biotronik Markets $10,000 Cardiac Airbag ICD Via Direct Sales Website
Biotronik's Cardiac Airbag is the first device tailored as a cheaper alternative to state-of-the-art ICDs as CMS weighs expanded coverage of the costly therapy
Guidant MADIT II Trial Could Support Doubling Of ICD-Eligible Population
Favorable results of the Guidant-sponsored MADIT II trial could increase the U.S. patient population that could benefit from implantable cardioverter defibrillator therapy from 300,000 to about 600,000, Guidant says